Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foretinib in metastatic gastric cancer
NCT00725712Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2007
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of foretinib in gastric cancer (GC), sponsored by GSK. Started Mar 2007; status: completed.
02
Drugs
foretinib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00725712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00725712.